Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
Study Identifier
P10-448
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
Observation of safety, tolerability and effectiveness of adalimumab (Humira) therapy in a large patient collective under everyday clinical conditions over 2 years.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 35036
Aachen, Germany, 52062
Status
Not applicable
Location
Site Reference ID/Investigator# 35510
Ahlen, Germany, 59227
Status
Not applicable
Location
Site Reference ID/Investigator# 35040
Ahrensburg, Germany, 22926
Status
Not applicable
Location
Site Reference ID/Investigator# 35043
Altenburg, Germany, 04600
Status
Not applicable
Location
Site Reference ID/Investigator# 35046
Altenholz, Germany, 24161
Status
Not applicable
Location
Site Reference ID/Investigator# 35049
Amberg, Germany, 92224
Status
Not applicable
Showing {first} - {last} of {total} Results